公司概覽
業務類別 Biotechnology
業務概覽 Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
公司地址 101 Redwood Shores Parkway, Redwood City, CA, USA, 94065
電話號碼 +1 650 327-3270
傳真號碼 +1 650 327-3218
公司網頁 https://www.corcept.com
員工數量 730
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Joseph K. Belanoff, M.D. Director, President and Chief Executive Officer 美元 1.18M 17/04/2026
Mr. G. Charles Robb Chief Business Officer and Secretary 美元 711.41K 17/04/2026
Mr. Atabak Mokari Chief Financial Officer and Treasurer 美元 566.35K 17/04/2026
Mr. Joseph Douglas Lyon Chief Accounting Officer and Chief Technology Officer -- 17/04/2026
Dr. Hazel Hunt, PhD Chief Scientific Officer -- 17/04/2026
Dr. William Guyer, Pharm.D. Chief Development Officer 美元 706.39K 17/04/2026
Mr. Justin Gunn President, Corcept Endocrinology -- 23/09/2026
 
董事會成員
董事會 職務 更新日期
Mr. David L. Mahoney Independent Director 17/04/2026
Mr. Daniel N. Swisher,Jr Independent Director 17/04/2026
Mr. George Leonard Baker, Jr Independent Director 17/04/2026
Dr. Gregg H. Alton, J.D. Independent Director 17/04/2026
Dr. Joseph K. Belanoff, M.D. Director, President and Chief Executive Officer 17/04/2026
Mr. James N. Wilson Chairman of the Board 17/04/2026
Ms. Kimberly Park Independent Director 17/04/2026
Mr. Joshua M. Murray Independent Director 17/04/2026
 
所屬ETF (更新日期: 07/11/2026 04:23)
代號 名稱 佔比% ▼ 持有日期
IWMiShares Russell 2000 ETF<0.000001%02/03/2026
IWOiShares Russell 2000 Growth ETF<0.000001%02/03/2026
JHSCJHancock Multifactor Small Cap ETF<0.000001%17/09/2026
JMIDJanus Henderson Mid Cap Growth Alpha ETF<0.000001%28/05/2026
JSMDJanus Henderson Small/Md Cp Gr Alpha ETF<0.000001%01/10/2026
JSMLJanus Henderson Small Cap Gr Alpha ETF<0.000001%25/08/2025
LSEQHarbor Long-Short Equity ETF<0.000001%31/10/2026
MHIGMilliman Healthcare Inflation Guard ETF<0.000001%20/10/2026
MHIPMilliman Healthcare Inflation Plus ETF<0.000001%30/10/2026
MSLCMorgan Stanley Pathway Large Cap Eq ETF<0.000001%02/07/2026
NXTISimplify Next Intangible Core Index ETF<0.000001%16/03/2026
PSCPrincipal US Small Cap ETF<0.000001%19/08/2025
PSCHInvesco S&P SmallCap Health Care ETF<0.000001%21/09/2026
QVMSInvesco S&P SmallCp 600 QVM Mlt-fctr ETF<0.000001%22/09/2026
RWJInvesco S&P SmallCap 600 Revenue ETF<0.000001%22/09/2026
RZGInvesco S&P SmallCap 600® Pure Gr ETF<0.000001%22/09/2026
SAAProShares Ultra SmallCap600<0.000001%21/09/2026
SCHASchwab US Small-Cap ETF™<0.000001%22/09/2026
SCOWPacer S&P SmCp 600 Qul FCF Aristcrts ETF<0.000001%29/09/2026
SGRTSMART Earnings Growth 30 ETF<0.000001%03/09/2026
  1    2    3    4    5    6    7    8   9    10  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.